Literature DB >> 30137549

Vaccine-Mediated Induction of an Ebolavirus Cross-Species Antibody Binding to Conserved Epitopes on the Glycoprotein Heptad Repeat 2/Membrane-Proximal External Junction.

Alberto Cagigi1, Aurélie Ploquin1, Thomas Niezold1, Yan Zhou1, Yaroslav Tsybovsky2, John Misasi1,3, Nancy J Sullivan1.   

Abstract

The membrane-proximal external regions (MPER) of the human immunodeficiency virus envelope glycoprotein (GP) generate broadly reactive antibody responses and are the focus of vaccine development efforts. The conservation of amino acids within filovirus GP heptad repeat region (HR)2/MPER suggests that it may also represent a target for a pan-filovirus vaccine. We immunized a cynomolgus macaque against Ebola virus (EBOV) using a deoxyribonucleic acid/adenovirus 5 prime/boost strategy, sequenced memory B-cell receptors, and tested the antibodies for functional activity against EBOV GP. Antibody ma-C10 bound to GP with an affinity of 48 nM and was capable of inducing antibody-dependent cellular cytotoxicity. Three-dimensional reconstruction of single-particle, negative-stained, electron microscopy showed that ma-C10 bound to the HR2/MPER, and enzyme-linked immunosorbent assay reveals it binds to residues 621-631. More importantly, ma-C10 was found to bind to the GP of the 3 most clinically relevant Ebolavirus species, suggesting that a cross-species immunogen strategy targeting the residues in this region may be a feasible approach for producing a pan-filovirus vaccine.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30137549      PMCID: PMC6249595          DOI: 10.1093/infdis/jiy450

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  44 in total

1.  FREALIGN: high-resolution refinement of single particle structures.

Authors:  Nikolaus Grigorieff
Journal:  J Struct Biol       Date:  2006-06-02       Impact factor: 2.867

2.  Spatial localization of the Ebola virus glycoprotein mucin-like domain determined by cryo-electron tomography.

Authors:  Erin E H Tran; James A Simmons; Alberto Bartesaghi; Charles J Shoemaker; Elizabeth Nelson; Judith M White; Sriram Subramaniam
Journal:  J Virol       Date:  2014-07-09       Impact factor: 5.103

3.  Case fatality rate for Ebola virus disease in west Africa.

Authors:  Adam J Kucharski; W John Edmunds
Journal:  Lancet       Date:  2014-09-23       Impact factor: 79.321

4.  Adenanthin, a new inhibitor of thiol-dependent antioxidant enzymes, impairs the effector functions of human natural killer cells.

Authors:  Marta Siernicka; Magdalena Winiarska; Malgorzata Bajor; Malgorzata Firczuk; Angelika Muchowicz; Malgorzata Bobrowicz; Cyril Fauriat; Jakub Golab; Daniel Olive; Radoslaw Zagozdzon
Journal:  Immunology       Date:  2015-07-08       Impact factor: 7.397

5.  Broadly neutralizing monoclonal antibodies 2F5 and 4E10 directed against the human immunodeficiency virus type 1 gp41 membrane-proximal external region protect against mucosal challenge by simian-human immunodeficiency virus SHIVBa-L.

Authors:  Ann J Hessell; Eva G Rakasz; David M Tehrani; Michael Huber; Kimberly L Weisgrau; Gary Landucci; Donald N Forthal; Wayne C Koff; Pascal Poignard; David I Watkins; Dennis R Burton
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

6.  Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques.

Authors:  Gene Garrard Olinger; James Pettitt; Do Kim; Cara Working; Ognian Bohorov; Barry Bratcher; Ernie Hiatt; Steven D Hume; Ashley K Johnson; Josh Morton; Michael Pauly; Kevin J Whaley; Calli M Lear; Julia E Biggins; Corinne Scully; Lisa Hensley; Larry Zeitlin
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-15       Impact factor: 11.205

7.  Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor.

Authors:  Jeffrey E Lee; Marnie L Fusco; Ann J Hessell; Wendelien B Oswald; Dennis R Burton; Erica Ollmann Saphire
Journal:  Nature       Date:  2008-07-10       Impact factor: 49.962

Review 8.  Ebolavirus vaccines for humans and apes.

Authors:  Hugues Fausther-Bovendo; Sabue Mulangu; Nancy J Sullivan
Journal:  Curr Opin Virol       Date:  2012-05-04       Impact factor: 7.090

Review 9.  Filoviruses: One of These Things is (not) Like the Other.

Authors:  Scott M Anthony; Steven B Bradfute
Journal:  Viruses       Date:  2015-09-29       Impact factor: 5.048

10.  RELION: implementation of a Bayesian approach to cryo-EM structure determination.

Authors:  Sjors H W Scheres
Journal:  J Struct Biol       Date:  2012-09-19       Impact factor: 2.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.